Trial Profile
A Phase 1 Study to Evaluate the Pharmacodynamics of RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2014
Price :
$35
*
At a glance
- Drugs Buprenorphine/samidorphan (Primary)
- Indications Cocaine-related disorders; Major depressive disorder
- Focus Adverse reactions; Pharmacodynamics
- 04 Dec 2014 New trial record